Deepa Pakianathan
Director/Board Member at THERAVANCE BIOPHARMA, INC.
Net worth: 330 805 $ as of 30/03/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jim Broderick | M | 55 |
Palleon Pharmaceuticals, Inc.
 Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | 19 years |
| Denise Scots-Knight | M | 64 | 16 years | |
| Michael Wyzga | M | 69 | 11 years | |
| John Lewicki | M | 72 | 20 years | |
| Rick Winningham | M | 64 | 11 years | |
| Richard Paulson | M | 56 | 4 years | |
| Rhonda Farnum | F | 59 | 6 years | |
| Charles Sermon | M | 55 | 9 years | |
| Tatjana Naranda | M | - | 19 years | |
| Christine Utter | F | 46 | 14 years | |
| Jeremy Charles Green | M | 49 | 6 years | |
| Garen Bohlin | M | 76 | 11 years | |
| Christy Oliger | F | 54 | 4 years | |
| Aziz Sawaf | M | 42 | 10 years | |
| Accumanno James | M | - | 3 years | |
| Michael Mano | M | 47 | 4 years | |
| David Johnson | M | 59 |
Palleon Pharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | 3 years |
| Jeremy Grant | M | 36 | 1 years | |
| John Hennessy | M | - |
Palleon Pharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | - |
| Richard Graham | M | - | - | |
| Su Zhen | M | 47 | 1 years | |
| Mansoor Mirza | M | 63 | 14 years | |
| Donal O'Connor | M | 73 | 9 years | |
| Laurie Alsup | M | 70 | 6 years | |
| Brett Grimaud | M | 50 | 3 years | |
| Dean Mitchell | M | 68 | 10 years | |
| Barry Greene | M | 60 | 11 years | |
| Eran Broshy | M | 65 | 10 years | |
| James Bochnowski | M | 80 |
Delphi Ventures, Inc.
 Delphi Ventures, Inc. Investment ManagersFinance Delphi Ventures Inc (Delphi Ventures) is a venture capital firm founded in 1988 by James Bochnowski. The firm is headquartered in San Mateo, California. | 36 years |
| Doug Roeder | M | 53 |
Delphi Ventures, Inc.
Delphi Ventures, Inc. Investment ManagersFinance Delphi Ventures Inc (Delphi Ventures) is a venture capital firm founded in 1988 by James Bochnowski. The firm is headquartered in San Mateo, California. | 26 years |
| John P. Richard | M | 66 | 9 years | |
| Susannah Gray | F | 63 | 1 years | |
| Aine Miller | M | 47 | - | |
| Jim Kelly | M | 43 | 1 years | |
| Chen Schor | M | 51 | 4 years | |
| Mike Mason | M | 49 | 5 years | |
| Jerome Zeldis | M | 74 | 12 years | |
| Anders Olof Adolf Ekblom | M | 70 | 9 years | |
| Sohanya Cheng | F | 41 | 3 years | |
| Lisa DiPaolo | F | - | 2 years | |
| Stuart Poulton | M | 51 | 2 years | |
| Jeff Gao | M | - |
San Francisco Conservatory of Music
| - |
| Stuart Knight | M | - | 10 years | |
| Jorge Ramentol Massana | M | - | 8 years | |
| Reshma Rangwala | M | 46 | 2 years | |
| Elhan Webb | F | - | 2 years | |
| Lori Hu | F | 38 |
Palleon Pharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | 6 years |
| Jayson Punwani | M | - |
Palleon Pharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | - |
| Joan Fanés Trillo | M | - | 8 years | |
| Karan Takhar | M | 32 |
Palleon Pharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | - |
| Brian Austad | M | - | 11 years | |
| Rajeev Dadoo | M | 54 |
Palleon Pharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | - |
| Amama Sadiq | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mark Litton | M | 56 | 14 years | |
| Randall Schatzman | M | 69 | 14 years | |
| August Moretti | M | 73 | 7 years | |
| Sharon Shacham | M | 53 | 13 years | |
| Yvonne Li | F | 64 | 12 years | |
| Jay Shepard | M | 65 | 3 years | |
| Paul Brannelly | M | 51 | 1 years | |
| Robert J. Stagg | M | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 2 years |
| Gerrit Klaerner | M | 53 | 6 years | |
| Paul Hastings | M | 64 | 12 years | |
| Jim Woody | M | 81 | 10 years | |
| Perry Karsen | M | 69 | 3 years | |
| Alastair MacKinnon | M | 53 | 7 years | |
| Hal Barron | M | 62 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 17 years |
| Rachel Robbins | F | 73 |
J.P. Morgan & Co. Ltd.
| 5 years |
| Michael Kauffman | M | 60 | 14 years | |
| Cameron Peters | M | 64 | - | |
| Peter John Fellner | M | 80 | 7 years | |
| Paul Cleveland | M | 67 | - | |
| Mark Oki | M | 55 | 9 years | |
| G. Kirk Raab | M | 88 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 10 years |
| Robert Azelby | M | 56 | 1 years | |
| Kevin Chow | M | 54 | 7 years | |
| William Young | M | 79 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 13 years |
| Michael J. Todisco | M | 59 | - | |
| George Tyson | M | - | - | |
| Cameron McDonough | M | 53 | 5 years | |
| Ronald A. Krasnow | M | 61 | - | |
| Ian Karp | M | - | - | |
| Lisa Meletta | F | - | - | |
| Huang I-Zu | M | - | - | |
| Alejandro A. Zaffaroni | M | 73 | 7 years | |
| Michael J. Simms | M | 62 | - | |
| Adam Koppel | M | 54 | 4 years | |
| Mike Burdick | M | - | 4 years | |
| Claire J. Lockey | F | 71 | 5 years | |
| Detlef F. Albrecht | M | 63 | - | |
| Bradford J. Shafer | M | 63 | 7 years | |
| Richard McVey | M | 63 |
J.P. Morgan & Co. Ltd.
| 8 years |
| Ed Colloton | M | - |
J.P. Morgan Partners LLC
 J.P. Morgan Partners LLC Investment ManagersFinance J.P. Morgan Partners LLC is a private equity firm founded in 1984. The firm headquartered located in New York City. | 4 years |
| Jonathan Silverstein | M | 57 | 4 years | |
| Burt Malkiel | M | 90 | 11 years | |
| William C. Houghton | M | 81 | - | |
| Richard H. Aldrich | M | 69 | 2 years | |
| Isaac Stein | M | 77 | 15 years | |
| Douglas Warner | M | 77 |
J.P. Morgan & Co. Ltd.
| 5 years |
| Asif Ali | M | 50 | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 92 | 92.00% |
| United Kingdom | 11 | 11.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Deepa Pakianathan
- Personal Network
